Indefinite Delivery Contract SPE2DX15D7911

This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for delivering essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract encompasses a broad spectrum of pharmaceutical and medical supply procurement, covering critical care items such as cardiovascular medications, diabetes management products, mental health treatments, pain relievers, infectious disease prevention tools, and general medical supplies. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp leverages its extensive supply chain and distribution capabilities to efficiently fulfill government requirements without any set-aside designations, demonstrating its strong position in the federal medical procurement market. This IDC, running through December 2025, enables the DLA to streamline the procurement of essential healthcare products for military treatment facilities, veterans' programs, and other federal medical institutions.